Added to YB: 2026-03-24
Pitch date: 2026-03-21
TEM [neutral]
Tempus AI, Inc.
+2.59%
current return
Author Info
No bio for this author
Company Info
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician’s desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.
Market Cap
$8.4B
Pitch Price
$47.90
Price Target
90.00 (+83%)
Dividend
N/A
EV/EBITDA
-57.12
P/E
-33.40
EV/Sales
7.05
Sector
Life Sciences Tools and Services
Category
growth
Tempus AI $TEM 2025 Q4 and Full Year Financial Report Analysis
TEM (earnings): Q4 rev $367.2M (+83% YoY, 33.5% organic) beat est $362.7M; Adj EPS -$0.04 beat -$0.047. Adj EBITDA $12.9M missed $22.3M on 70% R&D surge ($50.5M) for AI/MRD. FY26 guide: $1.59B rev, $65M EBITDA. MRD tests 4.7K (+56% QoQ), NRR 126%, $1.1B contracts. Non-GAAP gross margin 65.6% (data 90%). DCF PT $65-$75 baseline, $90+ bull case.
Read full article (8 min)